South America Artificial Retina Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
South America Artificial Retina Market Analysis — Presence
Geographical Analysis
Click countries to exploreCountry Analysis
South America Artificial Retina Market Analysis 2026
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| South America Artificial Retina Total | xxxx | xxxx | xxxx | 8.2% |
| Brazil | xxxx | xxxx | xxxx | 8.8% |
| Argentina | xxxx | xxxx | xxxx | 9.1% |
| Colombia | xxxx | xxxx | xxxx | 8% |
| Peru | xxxx | xxxx | xxxx | 8.4% |
| Chile | xxxx | xxxx | xxxx | 8.5% |
| Rest of South America | xxxx | xxxx | xxxx | 7.3% |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Segmentation Analysis
Type breakdown · Illustrative 2025 shares shown free · Full-period forecast in paid report.
Disclaimer: The charts and graphs are for illustrative purposes only and do not represent actual market values. To access accurate quantitative data, please request a paid report or request free sample.
To learn more about market share and segmentation, request the free sample pages.
Competitor Analysis
Competitive Landscape of the Artificial Retina Market
The Global Artificial Retina Market is distinguished by its competitive landscape, which is characterized by continuous technological advancements and intense competition. In order to introduce innovative artificial retina systems with improved patient outcomes and enhanced functionality, market participants are prioritizing research and development activities. Key actors employ strategic collaborations, partnerships, and acquisitions as prominent strategies to enhance their market presence and diversify their product portfolios.
September 2021: Bionic Vision Technologies (BVT) in Australia collaborated with Cirtec Medical to enhance its bionic eye technology. Cirtec's funding will support the advancement of BVT's state-of-the-art retinal implant. A global pivotal study for the system, which aims to restore vision for the blind, is scheduled for 2022. (Source: https://bionicvis.com/2021/09/06/australias-bionic-eye-advances-due-to-us-partnership/) August 2022: Second Sight Medical Products Inc. (US) announced the successful completion of its merger with Nano Precision Medical Inc. (US) and the subsequent rebranding of the company as Vivani Medical, Inc. (Source: https://vivani.com/second-sight-medical-products-announces-successful-completion-of-its-merger-with-nano-precision-medical-and-its-name-change-to-vivani-medical-inc/)
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Company 1 | ••• | ••• | ••• | ••• |
| Company 2 | ••• | ••• | ••• | ••• |
| Company 3 | ••• | ••• | ••• | ••• |
| Company 4 | ••• | ••• | ••• | ••• |
| Company 5 | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →Report Scope & Analysis
According to Cognitive Market Research, the global Artificial Retina market size was estimated at USD 2845.6 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 142.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031. .
- According to Cognitive Market Research, the Brazil Artificial Retina market size was valued at USD 60.90 million in 2024 and is believed to grow at a CAGR of 8.8% during the projected period. Artificial Retinas flourished in Brazil due to increasing prevalence of vision impairment and the expansion of business by market players.
- Argentina's Artificial Retina market had a market share of USD 23.90 million in 2024 and is believed to grow at a CAGR of 9.1% during the projected period. Argentina's development in economic growth and supportive regulatory environments.
- Colombia Artificial Retina market is believed to see growth at a CAGR of 8.0% during the projected period, with a market size of USD 12.66 million in 2024.
- Peru Artificial Retina market is believed to see growth at a CAGR of 8.4% during the projected period, with a market size of USD 11.67 million in 2024.
- Chile Artificial Retina market is believed to see growth at a CAGR of 8.5% during the projected period, with a market size of USD 10.24 million in 2024.
- The Rest of Latin America's Artificial Retina market is believed to see growth at a CAGR of 7.3% during the projected period, with a market size of USD 22.91 million in 2024.
The artificial retina market in Latin America is expanding as a result of growing knowledge about retinal illnesses and a rising desire for sophisticated healthcare solutions. Nevertheless, the expansion could be restrained due to restricted availability of state-of-the-art technologies and reduced healthcare spending in certain nations. Enhancing healthcare infrastructure and improving access to treatment could boost market possibilities in the region. In conclusion, the market in this region is driven by increasing research and development investments
Analyst Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The South America Artificial Retina Market Analysis is witnessing significant growth in the near future.
In 2023, the Epiretinal Implants segment accounted for a notable share of the South America Artificial Retina Market Analysis.
Supriya is a Team Lead at Cognitive Market Research & Consulting, leading research initiatives and strategic intelligence projects across the Healthcare, Pharmaceuticals, and Medical Devices & Consumables sectors. With more than two years of experience in market research and data analysis, she plays a key role in helping organizations navigate complex healthcare ecosystems, identify emerging opportunities, and make informed business decisions through data-driven insights and market intelligence.
Combining expertise in both primary and secondary research methodologies with a strong academic foundation in Marketing and Finance, Supriya oversees the execution of market assessments, competitive intelligence studies, forecasting models, stakeholder interviews, trend analysis, and custom consulting engagements. She collaborates with healthcare providers, pharmaceutical manufacturers, medical device companies, industry experts, and other key stakeholders to gather firsthand market perspectives while validating findings through extensive research. Her ability to interpret clinical, commercial, and market data enables clients to better understand industry developments, regulatory influences, innovation trends, and competitive dynamics.
In her leadership role, she manages end-to-end research projects and guides cross-functional teams in delivering high-quality market reports, consulting solutions, and strategic studies. Her expertise in market estimation, forecasting, and analytical modeling helps organizations evaluate market potential, assess growth opportunities, strengthen competitive positioning, and support strategic planning initiatives. By transforming complex healthcare and life sciences data into actionable business intelligence, she enables clients to make confident decisions in rapidly evolving market environments.
Driven by a passion for healthcare innovation and continuous professional development, Supriya remains committed to staying ahead of industry trends, technological advancements, and changing market conditions. Her leadership, analytical mindset, and dedication to research excellence help organizations mitigate risks, capitalize on emerging opportunities, and achieve sustainable growth across the global healthcare and life sciences landscape.
Frequently Asked Questions
★ Reviews
Rate this report
South America Artificial Retina Market Analysis — Table of Contents
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
| Type | Epiretinal Implants, Subretinal Implants, Suprachoroidal Implants, Optogenetic Implants, Others |
|---|---|
| Disease Indication | Retinitis Pigmentosa (RP), Age-Related Macular Degeneration (AMD), Stargardt Disease, Others |
| End-User | Multi-Specialty Hospitals, Ophthalmic Clinics, Research Institutes |
| List of Competitors | Second Sight Medical Products Inc., Pixium Vision, Nano Retina Inc., Retina Implant AG, Bionic Vision Technologies Pty Ltd., VisionCare Inc., iBIONICS, Monash Vision Group, Optobionics Corporation, Biomedical Technologies S.L. |
Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))
- 1.1 Top Competitors Analysis
- 1.1.1 Top Players Ranking 2024
- 1.1.2 New Product Launch Analysis
- 1.2 Company Profile (Data Subject to Availability) Sample Format
- 1.2.1 Second Sight Medical Products Inc.
- 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.1.2 Business Overview
- 1.2.1.3 R&D Investment (Subject to data availability)
- 1.2.1.4 Financials (Subject to data availability)
- 1.2.1.5 Product Types Specification
- 1.2.1.6 Business Strategy
- 1.2.1.7 Recent Developments
- 1.2.1.8 Management Change
- 1.2.1.9 S.W.O.T Analysis
- 1.2.2 Pixium Vision
- 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.2.2 Business Overview
- 1.2.2.3 R&D Investment (Subject to data availability)
- 1.2.2.4 Financials (Subject to data availability)
- 1.2.2.5 Product Types Specification
- 1.2.2.6 Business Strategy
- 1.2.2.7 Recent Developments
- 1.2.2.8 Management Change
- 1.2.2.9 S.W.O.T Analysis
- 1.2.3 Nano Retina Inc.
- 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.3.2 Business Overview
- 1.2.3.3 R&D Investment (Subject to data availability)
- 1.2.3.4 Financials (Subject to data availability)
- 1.2.3.5 Product Types Specification
- 1.2.3.6 Business Strategy
- 1.2.3.7 Recent Developments
- 1.2.3.8 Management Change
- 1.2.3.9 S.W.O.T Analysis
- 1.2.4 Retina Implant AG
- 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.4.2 Business Overview
- 1.2.4.3 R&D Investment (Subject to data availability)
- 1.2.4.4 Financials (Subject to data availability)
- 1.2.4.5 Product Types Specification
- 1.2.4.6 Business Strategy
- 1.2.4.7 Recent Developments
- 1.2.4.8 Management Change
- 1.2.4.9 S.W.O.T Analysis
- 1.2.5 Bionic Vision Technologies Pty Ltd.
- 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.5.2 Business Overview
- 1.2.5.3 R&D Investment (Subject to data availability)
- 1.2.5.4 Financials (Subject to data availability)
- 1.2.5.5 Product Types Specification
- 1.2.5.6 Business Strategy
- 1.2.5.7 Recent Developments
- 1.2.5.8 Management Change
- 1.2.5.9 S.W.O.T Analysis
- 1.2.6 VisionCare Inc.
- 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.6.2 Business Overview
- 1.2.6.3 R&D Investment (Subject to data availability)
- 1.2.6.4 Financials (Subject to data availability)
- 1.2.6.5 Product Types Specification
- 1.2.6.6 Business Strategy
- 1.2.6.7 Recent Developments
- 1.2.6.8 Management Change
- 1.2.6.9 S.W.O.T Analysis
- 1.2.7 iBIONICS
- 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.7.2 Business Overview
- 1.2.7.3 R&D Investment (Subject to data availability)
- 1.2.7.4 Financials (Subject to data availability)
- 1.2.7.5 Product Types Specification
- 1.2.7.6 Business Strategy
- 1.2.7.7 Recent Developments
- 1.2.7.8 Management Change
- 1.2.7.9 S.W.O.T Analysis
- 1.2.8 Monash Vision Group
- 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.8.2 Business Overview
- 1.2.8.3 R&D Investment (Subject to data availability)
- 1.2.8.4 Financials (Subject to data availability)
- 1.2.8.5 Product Types Specification
- 1.2.8.6 Business Strategy
- 1.2.8.7 Recent Developments
- 1.2.8.8 Management Change
- 1.2.8.9 S.W.O.T Analysis
- 1.2.9 Optobionics Corporation
- 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.9.2 Business Overview
- 1.2.9.3 R&D Investment (Subject to data availability)
- 1.2.9.4 Financials (Subject to data availability)
- 1.2.9.5 Product Types Specification
- 1.2.9.6 Business Strategy
- 1.2.9.7 Recent Developments
- 1.2.9.8 Management Change
- 1.2.9.9 S.W.O.T Analysis
- 1.2.10 Biomedical Technologies S.L.
- 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.10.2 Business Overview
- 1.2.10.3 R&D Investment (Subject to data availability)
- 1.2.10.4 Financials (Subject to data availability)
- 1.2.10.5 Product Types Specification
- 1.2.10.6 Business Strategy
- 1.2.10.7 Recent Developments
- 1.2.10.8 Management Change
- 1.2.10.9 S.W.O.T Analysis
- 1.2.1 Second Sight Medical Products Inc.
- 1.1 Top Competitors Analysis
Chapter 2. Global Artificial Retina Market Analysis
- 2.1 Global Artificial Retina Market Analysis
- 2.2 Global Artificial Retina Market Analysis by Type
- 2.3 Global Artificial Retina Market Analysis by Disease Indication
- 2.4 Global Artificial Retina Market Analysis by End-User
Chapter 3. South America Artificial Retina Market Analysis
- 3.1 South America Artificial Retina Market Analysis
- 3.2 South America Artificial Retina Market Analysis by Country
- 3.3 South America Artificial Retina Market Analysis by Type
- 3.4 South America Artificial Retina Market Analysis by Disease Indication
- 3.5 South America Artificial Retina Market Analysis by End-User
- 3.6 South America Artificial Retina Market Analysis by Key Players
Chapter 4. Brazil Artificial Retina Market Analysis
- 4.1 Brazil Artificial Retina Market Analysis
- 4.2 Brazil Artificial Retina Market Analysis by Type
- 4.3 Brazil Artificial Retina Market Analysis by Disease Indication
- 4.4 Brazil Artificial Retina Market Analysis by End-User
- 4.5 Brazil Artificial Retina Market Analysis by Key Players
Chapter 5. Argentina Artificial Retina Market Analysis
- 5.1 Argentina Artificial Retina Market Analysis
- 5.2 Argentina Artificial Retina Market Analysis by Type
- 5.3 Argentina Artificial Retina Market Analysis by Disease Indication
- 5.4 Argentina Artificial Retina Market Analysis by End-User
- 5.5 Argentina Artificial Retina Market Analysis by Key Players
Chapter 6. Colombia Artificial Retina Market Analysis
- 6.1 Colombia Artificial Retina Market Analysis
- 6.2 Colombia Artificial Retina Market Analysis by Type
- 6.3 Colombia Artificial Retina Market Analysis by Disease Indication
- 6.4 Colombia Artificial Retina Market Analysis by End-User
- 6.5 Colombia Artificial Retina Market Analysis by Key Players
Chapter 7. Peru Artificial Retina Market Analysis
- 7.1 Peru Artificial Retina Market Analysis
- 7.2 Peru Artificial Retina Market Analysis by Type
- 7.3 Peru Artificial Retina Market Analysis by Disease Indication
- 7.4 Peru Artificial Retina Market Analysis by End-User
- 7.5 Peru Artificial Retina Market Analysis by Key Players
Chapter 8. Chile Artificial Retina Market Analysis
- 8.1 Chile Artificial Retina Market Analysis
- 8.2 Chile Artificial Retina Market Analysis by Type
- 8.3 Chile Artificial Retina Market Analysis by Disease Indication
- 8.4 Chile Artificial Retina Market Analysis by End-User
- 8.5 Chile Artificial Retina Market Analysis by Key Players
Chapter 9. Rest of South America Artificial Retina Market Analysis
- 9.1 Rest of South America Artificial Retina Market Analysis
- 9.2 Rest of South America Artificial Retina Market Analysis by Type
- 9.3 Rest of South America Artificial Retina Market Analysis by Disease Indication
- 9.4 Rest of South America Artificial Retina Market Analysis by End-User
- 9.5 Rest of South America Artificial Retina Market Analysis by Key Players
Chapter 10. Type Analysis
- 10.1 Epiretinal Implants
- 10.2 Subretinal Implants
- 10.3 Suprachoroidal Implants
- 10.4 Optogenetic Implants
- 10.5 Others
Chapter 11. Disease Indication Analysis
- 11.1 Retinitis Pigmentosa (RP)
- 11.2 Age-Related Macular Degeneration (AMD)
- 11.3 Stargardt Disease
- 11.4 Others
Chapter 12. End-User Analysis
- 12.1 Multi-Specialty Hospitals
- 12.2 Ophthalmic Clinics
- 12.3 Research Institutes
Chapter 13. Qualitative Analysis (Subject to Data Availability)
- 13.1 Market Drivers
- 13.2 Market Restraints
- 13.3 Market Trends
- 13.4 Market Opportunity
- 13.5 Technological Road Map (Subject to Data Availability)
- 13.6 Product Life Cycle (Subject to Data Availability)
- 13.7 Customer and Buyer Behavior Analysis
- 13.7.1 Digital Engagement, Customer Experience & Relationship Analysis
- 13.7.2 Customer Buying Behavior & Purchase Decision Analysis
- 13.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
- 13.7.4 Pricing, Affordability & Value Perception Analysis
- 13.7.5 Customer Segmentation & Demand Pattern Analysis
- 13.8 Industrial Chain Analysis (Subject to Data Availability)
- 13.8.1 Industry Chain Analysis
- 13.8.2 Manufacturing Cost Analysis
- 13.8.3 Supply Side Analysis
- 13.8.3.1 Raw Material Analysis
- 13.8.3.2 Raw Material Procurement Analysis
- 13.8.3.3 Raw Material Price Trend Analysis
- 13.9 PESTEL Analysis
- 13.9.1 Environmental Factors
- 13.9.2 Legal Factors
- 13.9.3 Technological Factors
- 13.9.4 Economic Factors
- 13.9.5 Political Factors
- 13.9.6 Social Factors
- 13.10 Porter’s Five Forces Analysis
- 13.10.1 Degree of Competition
- 13.10.2 Threat of Substitutes
- 13.10.3 Threat of New Entrants
- 13.10.4 Bargaining Power of Buyers
- 13.10.5 Bargaining Power of Suppliers
- 13.11 Patent Analysis (Subject to Data Availability)
- 13.12 ESG Analysis
- 13.13 Geopolitical Outlook
- 13.13.1 Global Power Realignment & Strategic Alliances
- 13.13.2 Geopolitical Risk Landscape & Conflict Hotspots
- 13.13.3 International Trade Relations & Market Access Environment
- 13.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
- 13.13.5 Supply Chain Resilience, Localization & Resource Nationalism
- 13.13.6 Technology Sovereignty & Digital Geopolitics
- 13.13.7 Strategic Implications for Investment, Growth & Market Entry
- 13.14 AI & Market Transformation
- 13.14.1 Competitive Landscape Disruption & Strategic Shifts
- 13.14.2 AI-Driven Transformation of Industry Value Chain
- 13.14.3 Evolution of Business Models & Revenue Streams
- 13.14.4 AI-Driven Product, Service & Innovation Transformation
- 13.14.5 Customer Behavior, AI Adoption & Future Market Evolution
Chapter 14. Research Findings
- 14.1 Key Takeaways
- 14.2 Analyst Point of View
- 14.3 Assumptions and Acronyms
Chapter 15. Research Methodology and Sources
- 15.1 Primary Data Collection
- 15.1.1 Steps for Primary Data Collection
- 15.1.1.1 Identification of KOL
- 15.1.2 Backward Integration
- 15.1.3 Forward Integration
- 15.1.4 How Primary Research Help Us
- 15.1.5 Modes of Primary Research
- 15.1.1 Steps for Primary Data Collection
- 15.2 Secondary Research
- 15.2.1 How Secondary Research Help Us
- 15.2.2 Sources of Secondary Research
- 15.3 Data Validation
- 15.3.1 Data Triangulation
- 15.4 Data Representation
- 15.1 Primary Data Collection
Athenaeum AI Dashboard
Our Proprietary Methodology
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the South America Artificial Retina Market Analysis Market analysis.
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
Data Assurance Metrics
Analytical Coverage
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Sources from the Medical Devices and Consumables Industry
The Three Pillars of End-to-End Market Research Services
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the South America Artificial Retina Market Analysis market.
Market Survey
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the south america artificial retina market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
- Buyer intent & sentiment analysis
- Purchase cycle mapping
- Price sensitivity research
- Channel preference profiling
- Competitive perception study
Customized Market Data & Reports
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
- Ready syndicate report
- Custom data scope & segmentation
- Excel quantitative models
- Board-ready PPT with key findings
- Secure cloud portal access
Strategic Consultation
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
- Dedicated analyst assigned to you
- Live walkthrough of findings
- Strategic Q&A sessions
- Go-to-market recommendations
- NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
